Choudhury, Shelly Baker, Susan
Published in
Clinical reviews in allergy & immunology
Eosinophilic esophagitis (EoE) is a chronic, relapsing inflammatory disease of the esophagus, characterized by the presence of significant esophageal mucosal eosinophilic infiltrates. The clinical presentation of EoE in childhood may include failure to thrive and feeding intolerance. The complication of food impaction is often related to the presen...
Mennini, Maurizio Fiocchi, Alessandro Giovanni Cafarotti, Arianna Montesano, Marilisa Mauro, Angela Villa, Maria Pia Di Nardo, Giovanni
Published in
The World Allergy Organization Journal
Food protein-induced allergic proctocolitis (FPIAP) is a condition characterized by inflammatory changes in the distal colon in response to one or more foreign food proteins because of immune-mediated reactions. FPIAP prevalence estimates range widely from 0.16% in healthy children and 64% in patients with blood in stools. In clinical practice, FPI...
Miyata, Jun Fukunaga, Koichi Kawashima, Yusuke Ohara, Osamu Kawana, Akihiko Asano, Koichiro Arita, Makoto
Published in
Prostaglandins & other lipid mediators
Polyunsaturated fatty acids (PUFAs), represented by the omega-6 fatty acid arachidonic acid (AA) and omega-3 fatty acid docosahexaenoic acid (DHA), are essential components of the human body. PUFAs are converted enzymatically into bioactive lipid mediators, including AA-derived cysteinyl leukotrienes (cys-LTs) and lipoxins and DHA-derived protectin...
Orak, Yavuz Kocarslan, Aydemir Boran, Omer Faruk Acıpayam, Mehmet Eroglu, Erdinc Kirisci, Mehmet Doganer, Adem
Abstract Objective: Our goal was to compare the operative and postoperative effects of del Nido cardioplegia (DN group) and blood cardioplegia (BC group) performed in cardiac surgery. Methods: A total of 83 patients were included, separated into DN group and BC group. The operative and postoperative effects of the two groups were compared for the f...
Singh, Dave Wedzicha, Jadwiga A. Siddiqui, Salman de la Hoz, Alberto Xue, Wenqiong Magnussen, Helgo Miravitlles, Marc Chalmers, James D. Calverley, Peter M. A.
Published in
Respiratory Research
BackgroundChronic obstructive pulmonary disease (COPD) is characterised by progressive airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which contribute to disease progression, is important to guide preventative treatment and improve outcomes. Blood eosinophils are a biomarker for patient responsiveness to inhaled cort...
Liang, Zhuoping Yan, Bing Liu, Chang Tan, Ruyu Wang, Chengshuo Zhang, Luo
Published in
Allergy, Asthma & Clinical Immunology
BackgroundEosinophilic chronic rhinosinusitis with nasal polyps (ECRSwNP) exhibits a poorer outcome compared with non-eosinophilic chronic rhinosinusitis with nasal polyps (nonECRSwNP), so it is significant to identify effective markers to differentiate ECRSwNP in guiding the treatment strategies of these patients. Although arachidonate 15-lipoxyge...
Jin, Hyun Jung
Published in
Yeungnam University Journal of Medicine
Severe asthma patients comprise about 3% to 13% of all asthma patients, but they have higher hospital utilization rates and higher medical costs than those of nonsevere asthma patients. Treatment methods for severe asthma patients are still lacking; however, the recent development of biologics is expected to have a positive effect. The biological t...
Mei, Xu Ye, Zhanhong Chang, Yuqing Huang, Shiguang Song, Jianping Lu, Fangli
Published in
Parasites & Vectors
BackgroundAlthough Plasmodium parasites and intestinal helminths share common endemic areas, the mechanisms of these co-infections on the host immune response remain not fully understood. Liver involvement in severe Plasmodium falciparum infections is a significant cause of morbidity and mortality. However, the effect of pre-existing Trichinella sp...
Szefler, Stanley J Casale, Thomas B Haselkorn, Tmirah Yoo, Bongin Ortiz, Benjamin Kattan, Meyer Busse, William W
Published in
The journal of allergy and clinical immunology. In practice
Greater severity in childhood asthma negatively impacts functioning and quality of life. Omalizumab is effective in children aged 6 years or older with moderate to severe persistent asthma, but predicting responsiveness in severe disease requires further study. To assess response to omalizumab treatment among children using indicators of asthma sev...
Pelaia, Corrado Busceti, Maria Teresa Crimi, Claudia Carpagnano, Giovanna Elisiana Lombardo, Nicola Terracciano, Rosa Vatrella, Alessandro Pelaia, Girolamo
Published in
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
The humanized monoclonal antibody benralizumab targets the α subunit of the interleukin-5 (IL-5) receptor and the FcγRIIIa receptor expressed by natural killer cells. Through this dual mechanism of action, benralizumab neutralizes the pro-eosinophil functions of IL-5 and promotes eosinophil apoptosis. The present real-life study aimed to evaluate, ...